Carcinogenesis, Vol 18, 795-799, Copyright © 1997 by Oxford University Press
DJ Kelley, JR Mestre, K Subbaramaiah, PG Sacks, SP Schantz, T Tanabe, H Inoue, JT Ramonetti and AJ Dannenberg
Cyclooxygenase may be important in the pathogenesis of smoking-related
cancer because it activates carcinogens and catalyzes prostaglandin
biosynthesis. We determined the effects of benzo[a]pyrene (B[a]P), a
polycyclic aromatic hydrocarbon in tobacco smoke, on cyclooxygenase-2
(Cox-2) mRNA, protein and synthesis of prostaglandin E2 (PGE2) in normal
and transformed oral epithelial cells. Treatment with B[a]P caused a
dose-dependent increase in production of PGE2, with a maximal increase of
approximately 100%. Enhanced synthesis of PGE2 was associated with
increased amounts of Cox-2 protein. B[a]P also caused a two-fold increase
in Cox-2 mRNA in both normal and transformed cells. Transient transfections
with a Cox-2 promoter construct showed that B[a]P-mediated induction of
Cox-2 mRNA reflected increased transcription. Levels of Cox-1 were
unaffected by B[a]P. B[e]P did not affect the synthesis of PGE2 or amounts
of Cox-2. These data are important because B[a]P-mediated induction of
Cox-2 may predispose to carcinogenesis by enhancing the production of
mutagens and the synthesis of prostaglandins.
ARTICLES
Benzo[a]pyrene up-regulates cyclooxygenase-2 gene expression in oral epithelial cells
Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
V. A. Papadimitrakopoulou, W. N. William Jr., A. J. Dannenberg, S. M. Lippman, J. J. Lee, F. G. Ondrey, D. E. Peterson, L. Feng, A. Atwell, A. K. El-Naggar, et al. Pilot Randomized Phase II Study of Celecoxib in Oral Premalignant Lesions Clin. Cancer Res., April 1, 2008; 14(7): 2095 - 2101. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Deeb, R. K. Upmacis, B. D. Lamon, S. S. Gross, and D. P. Hajjar Maintaining Equilibrium by Selective Targeting of Cyclooxygenase Pathways: Promising Offensives Against Vascular Injury Hypertension, January 1, 2008; 51(1): 1 - 7. [Full Text] [PDF] |
||||
![]() |
C. A. Martey, C. J. Baglole, T. A. Gasiewicz, P. J. Sime, and R. P. Phipps The aryl hydrocarbon receptor is a regulator of cigarette smoke induction of the cyclooxygenase and prostaglandin pathways in human lung fibroblasts Am J Physiol Lung Cell Mol Physiol, September 1, 2005; 289(3): L391 - L399. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Gross, J. O. Boyle, J. D. Morrow, M. K. Williams, C. S. Moskowitz, K. Subbaramaiah, A. J. Dannenberg, and A. J. Duffield-Lillico Levels of Prostaglandin E Metabolite, the Major Urinary Metabolite of Prostaglandin E2, Are Increased in Smokers Clin. Cancer Res., August 15, 2005; 11(16): 6087 - 6093. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mascaux, B. Martin, J-M. Verdebout, V. Ninane, and J-P. Sculier COX-2 expression during early lung squamous cell carcinoma oncogenesis Eur. Respir. J., August 1, 2005; 26(2): 198 - 203. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Martey, S. J. Pollock, C. K. Turner, K. M. A. O'Reilly, C. J. Baglole, R. P. Phipps, and P. J. Sime Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer Am J Physiol Lung Cell Mol Physiol, November 1, 2004; 287(5): L981 - L991. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ramesh, S. A. Walker, D. B. Hood, M. D. Guillen, K. Schneider, and E. H. Weyand Bioavailability and Risk Assessment of Orally Ingested Polycyclic Aromatic Hydrocarbons International Journal of Toxicology, September 1, 2004; 23(5): 301 - 333. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Tsao, E. S. Kim, and W. K. Hong Chemoprevention of Cancer CA Cancer J Clin, May 1, 2004; 54(3): 150 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Almahmeed, J. O. Boyle, E. G. Cohen, J. F. Carew, B. Du, N. K. Altorki, L. Kopelovich, J.-L. Fang, P. Lazarus, K. Subbaramaiah, et al. Benzo[a]pyrene phenols are more potent inducers of CYP1A1, CYP1B1 and COX-2 than benzo[a]pyrene glucuronides in cell lines derived from the human aerodigestive tract Carcinogenesis, May 1, 2004; 25(5): 793 - 799. [Full Text] [PDF] |
||||
![]() |
J. R. Brown and R. N. DuBois Cyclooxygenase-2 in Lung Carcinogenesis and Chemoprevention: Roger S. Mitchell Lecture Chest, May 1, 2004; 125(5_suppl): 134S - 140S. [Full Text] [PDF] |
||||
![]() |
S. Goodin and S. J. Shiff NSAIDs for the Chemoprevention of Oral Cancer: Promise or Pessimism?: Commentary re J. L. Mulshine et al., Randomized, Double-Blind, Placebo-Controlled, Phase IIB Trial of the Cyclooxygenase Inhibitor Ketorolac as an Oral Rinse in Oropharyngeal Leukoplakia. Clin. Cancer Res., 10: 1565-1573, 2004. Clin. Cancer Res., March 1, 2004; 10(5): 1561 - 1564. [Full Text] [PDF] |
||||
![]() |
B. W. Chang, D. H. Kim, D. P. Kowalski, J. A. Burleson, Y. H. Son, L. D. Wilson, and B. G. Haffty Prognostic Significance of Cyclooxygenase-2 in Oropharyngeal Squamous Cell Carcinoma Clin. Cancer Res., March 1, 2004; 10(5): 1678 - 1684. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Mao, M. D. Roth, K. J. Serio, F. Baratelli, L. Zhu, E. C. Holmes, R. M. Strieter, and S. M. Dubinett Celecoxib Modulates the Capacity for Prostaglandin E2 and Interleukin-10 Production in Alveolar Macrophages from Active Smokers Clin. Cancer Res., December 1, 2003; 9(16): 5835 - 5841. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Gallo, N. Schiavone, L. Papucci, I. Sardi, L. Magnelli, A. Franchi, E. Masini, and S. Capaccioli Down-Regulation of Nitric Oxide Synthase-2 and Cyclooxygenase-2 Pathways by p53 in Squamous Cell Carcinoma Am. J. Pathol., August 1, 2003; 163(2): 723 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Minter, J. W. Eveson, S. Huntley, D. J. E. Elder, and A. Hague The Cyclooxygenase 2-selective Inhibitor NS398 Inhibits Proliferation of Oral Carcinoma Cell Lines by Mechanisms Dependent and Independent of Reduced Prostaglandin E2 Synthesis Clin. Cancer Res., May 1, 2003; 9(5): 1885 - 1897. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Rudra-Ganguly, S. T. Reddy, P. Korge, and H. R. Herschman Diesel Exhaust Particle Extracts and Associated Polycyclic Aromatic Hydrocarbons Inhibit Cox-2-dependent Prostaglandin Synthesis in Murine Macrophages and Fibroblasts J. Biol. Chem., October 11, 2002; 277(42): 39259 - 39265. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. PARMAN and P. G. WELLS Embryonic prostaglandin H synthase-2 (PHS-2) expression and benzo[a]pyrene teratogenicity in PHS-2 knockout mice FASEB J, July 1, 2002; 16(9): 1001 - 1009. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Subbaramaiah, P. Bulic, Y. Lin, A. J. Dannenberg, and D. S. Pasco Development and Use of a Gene Promoter-Based Screen to Identify Novel Inhibitors of Cyclooxygenase-2 Transcription J Biomol Screen, April 1, 2001; 6(2): 101 - 110. [Abstract] [PDF] |
||||
![]() |
F. W. Wiese, P. A. Thompson, and F. F. Kadlubar Carcinogen substrate specificity of human COX-1 and COX-2 Carcinogenesis, January 1, 2001; 22(1): 5 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Vogel, A.-M. J.F. Boerboom, C. Baechle, C. El-Bahay, R. Kahl, G. H. Degen, and J. Abel Regulation of prostaglandin endoperoxide H synthase-2 induction by dioxin in rat hepatocytes: possible c-Src-mediated pathway Carcinogenesis, December 1, 2000; 21(12): 2267 - 2274. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. HONG, F. G. ONDREY, I. M. AVIS, Z. CHEN, E. LOUKINOVA, P. F. CAVANAUGH JR, C. VAN WAES, and J. L. MULSHINE Cyclooxygenase regulates human oropharyngeal carcinomas via the proinflammatory cytokine IL-6: a general role for inflammation? FASEB J, August 1, 2000; 14(11): 1499 - 1507. [Abstract] [Full Text] |
||||
![]() |
Z. Yan, K. Subbaramaiah, T. Camilli, F. Zhang, T. Tanabe, T. A. McCaffrey, A. J. Dannenberg, and B. B. Weksler Benzo[a]pyrene Induces the Transcription of Cyclooxygenase-2 in Vascular Smooth Muscle Cells. EVIDENCE FOR THE INVOLVEMENT OF EXTRACELLULAR SIGNAL-REGULATED KINASE AND NF-kappa B J. Biol. Chem., February 18, 2000; 275(7): 4949 - 4955. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Subbaramaiah, N. Altorki, W. J. Chung, J. R. Mestre, A. Sampat, and A. J. Dannenberg Inhibition of Cyclooxygenase-2 Gene Expression by p53 J. Biol. Chem., April 16, 1999; 274(16): 10911 - 10915. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. El-Bayoumy, M. Iatropoulos, S. Amin, D. Hoffmann, and E. L. Wynder Increased Expression of Cyclooxygenase-2 in Rat Lung Tumors Induced by the Tobacco-specific Nitrosamine 4-(Methylnitrosamino)-4-(3-pyridyl)-1-butanone: The Impact of a High-Fat Diet Cancer Res., April 1, 1999; 59(7): 1400 - 1403. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Chan, J. O. Boyle, E. K. Yang, F. Zhang, P. G. Sacks, J. P. Shah, D. Edelstein, R. A. Soslow, A. T. Koki, B. M. Woerner, et al. Cyclooxygenase-2 Expression Is Up-Regulated in Squamous Cell Carcinoma of the Head and Neck Cancer Res., March 1, 1999; 59(5): 991 - 994. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zhang, N. K. Altorki, J. R. Mestre, K. Subbaramaiah, and A. J. Dannenberg Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells Carcinogenesis, March 1, 1999; 20(3): 445 - 451. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zhang, K. Subbaramaiah, N. Altorki, and A. J. Dannenberg Dihydroxy Bile Acids Activate the Transcription of Cyclooxygenase-2 J. Biol. Chem., January 23, 1998; 273(4): 2424 - 2428. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Mestre, P. J. Mackrell, D. E. Rivadeneira, P. P. Stapleton, T. Tanabe, and J. M. Daly Redundancy in the Signaling Pathways and Promoter Elements Regulating Cyclooxygenase-2 Gene Expression in Endotoxin-treated Macrophage/Monocytic Cells J. Biol. Chem., February 2, 2001; 276(6): 3977 - 3982. [Abstract] [Full Text] [PDF] |
||||












